Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A clinical study showing the expression characteristics of cuproptosis markers in cases with Wilson disease. | Medicine (Baltimore) | 2024 | 39809184 | PubTator, text mining | PubMed |
| Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer. | Front Cell Dev Biol | 2024 | 39763583 | PubTator, text mining | PubMed |
| Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment. | Heliyon | 2024 | 39719989 | PubTator, text mining | PubMed |
| Pharmacogenetics of colorectal cancer in a third-level hospital in Valencia. | Adv Lab Med | 2024 | 39713544 | PubTator, text mining | PubMed |
| Clinical implications of a gain-of-function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines. | Front Pharmacol | 2024 | 39703399 | PubTator, text mining | PubMed |
| Influence of DPYD gene polymorphisms on 5-Fluorouracil toxicities in Thai colorectal cancer patients. | Cancer Chemother Pharmacol | 2024 | 39652193 | PubTator, text mining | PubMed |
| Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer: A Secondary Analysis of the PREPARE Randomized Clinical Trial. | JAMA Netw Open | 2024 | 39641926 | PubTator, text mining | PubMed |
| Exploring the preparedness of hospital pharmacists practising in Southwest London for implementing pharmacogenomics testing. | J Pharm Policy Pract | 2024 | 39640415 | PubTator, text mining | PubMed |
| Effects of precision health management combined with dual-energy bone densitometer treatment on bone biomarkers in senile osteoporosis patients. | Exp Gerontol | 2024 | 39603369 | PubTator, text mining | PubMed |
| MIR27A rs895819 CC Genotype Severely Reduces miR-27a Plasma Expression Levels. | Genes (Basel) | 2024 | 39596691 | PubTator, text mining | PubMed |
| Are the Common Genetic 3'UTR Variants in ADME Genes Playing a Role in Tolerance of Breast Cancer Chemotherapy? | Int J Mol Sci | 2024 | 39596349 | PubTator, text mining | PubMed |
| Lethal 5-Fluorouracil Toxicity in a Carrier of DPYD c.704G>A (p.R235Q). | JCO Precis Oncol | 2024 | 39576955 | PubTator, text mining | PubMed |
| Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy. | Nat Commun | 2024 | 39562821 | PubTator, text mining | PubMed |
| SNPs and blood inflammatory marker featured machine learning for predicting the efficacy of fluorouracil-based chemotherapy in colorectal cancer. | Sci Rep | 2024 | 39532939 | PubTator, text mining | PubMed |
| DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol. | BMC Cancer | 2024 | 39516829 | PubTator, text mining | PubMed |
| Grounded situation recognition under data scarcity. | Sci Rep | 2024 | 39448681 | PubTator, text mining | PubMed |
| Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population. | Daru | 2024 | 39424756 | PubTator, text mining | PubMed |
| Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant. | Front Pharmacol | 2024 | 39376610 | PubTator, text mining | PubMed |
| Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences. | Sci Rep | 2024 | 39354004 | PubTator, text mining | PubMed |
| Pharmacogenetics of DPYD and treatment-related mortality on fluoropyrimidine chemotherapy for cancer patients: a meta-analysis and trial sequential analysis. | BMC Cancer | 2024 | 39350200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=12